A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment For High Anatomic Stage ER-pos/HER2-neg Breast Cancer With RS</=25 (RxFINE-Low)
NCT07391774 · NOT YET RECRUITING · Phase 3
ReadTheTrial indexes 4 studies for Anatomic Stage Ii Breast Cancer Ajcc V8. The most common development stage is Phase 3 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
4 clinical trials found for Anatomic Stage Ii Breast Cancer Ajcc V8.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 2 | 50% |
| Phase 2 | 2 | 50% |
There are 4 clinical trials listed for Anatomic Stage Ii Breast Cancer Ajcc V8. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Anatomic Stage Ii Breast Cancer Ajcc V8 trials are distributed across: Phase 3 (2), Phase 2 (2).